CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net income (loss)	$ 10,544	$ (100,972)
Adjustments to reconcile net income (loss) to cash used in operating activities:
Depreciation and amortization	289,108	306,147
Net amortization of debt issuance costs, discounts and premiums as interest	18,644	15,529
Straight line rental income	(6,867)	5,530
Loss on early extinguishment of debt	282	791
Loss on asset impairment, net	9,517	9,720
Gains on equity securities, net	(48,837)	(2,737)
Equity in losses (earnings) of an investee	1,840	(4,277)
Gain on sale of real estate	(41,959)	(44,235)
Other non-cash income, net	(897)	(1,635)
Changes in assets and liabilities:
Due from related persons	(873)	(19,949)
Other assets	11,743	4,990
Accounts payable and other liabilities	163,155	(13,096)
Due to related persons	(3,442)	(8,692)
Net cash provided by operating activities	401,958	147,114
Cash flows from investing activities:
Acquisition of real estate properties	(165,843)	(2,765)
Proceeds from sale of TA common shares	101,892	0
Proceeds from sale of tradenames and trademarks	89,400	0
Real estate improvements	(118,785)	(68,790)
Hotel managers’ purchases with restricted cash	(3,943)	(3,951)
Net proceeds from sale of real estate	148,245	517,956
Investment in Sonesta	0	(45,470)
Net cash provided by investing activities	50,966	396,980
Cash flows from financing activities:
Proceeds from mortgage notes payable, net of discounts	576,946	0
Repayment of mortgage notes payable	(1,142)	0
Repayment of senior unsecured notes	(500,000)	(500,000)
Borrowings under revolving credit facility	0	20,000
Repayments of revolving credit facility	0	(925,000)
Deferred financing costs	(38,548)	(2,959)
Repurchase of common shares	(797)	(463)
Distributions to common shareholders	(99,275)	(4,953)
Net cash used in financing activities	(62,816)	(1,413,375)
Increase (decrease) in cash and cash equivalents and restricted cash	390,108	(869,281)
Cash and cash equivalents and restricted cash at beginning of period	45,420	947,418
Cash and cash equivalents and restricted cash at end of period	$ 435,528	$ 78,137